Phemindole treatment reduces STIM1 expression by reducing the interaction between STIM1 and Orai1, resulting in decreased cell migration in vitro through the regulation of FAK; a reduction in tumor growth in vivo was also observed [60]. Here, ORAI1 is linked to neoplasm.